Most Recent

The Donald Danforth Plant Science Center researcher links complex traits to the genes that underlie them.

0 Comments

image: Jason Holliday: Tree Tracker

Jason Holliday: Tree Tracker

By | February 1, 2016

Associate Professor, Virginia Tech, Department of Forest Resources and Environmental Conservation. Age: 37

0 Comments

image: Yun “Nancy” Huang: Eager for Epigenetics

Yun “Nancy” Huang: Eager for Epigenetics

By | August 1, 2015

Assistant Professor, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston. Age: 35

0 Comments

image: Matthew Powner: Origin Solver

Matthew Powner: Origin Solver

By | March 1, 2014

Lecturer, Department of Chemistry, University College London. Age: 32

2 Comments

image: Thomas Gregor: Biological Quantifier

Thomas Gregor: Biological Quantifier

By | November 1, 2013

Assistant Professor, Physics, Princeton University. Age: 39

0 Comments

image: Yoav Gilad: Gene Regulator

Yoav Gilad: Gene Regulator

By | October 1, 2013

Professor, Department of Human Genetics, University of Chicago. Age: 38

3 Comments

image: Mary O’Connor: Warming Up

Mary O’Connor: Warming Up

By | June 1, 2013

Assistant Professor, Department of Zoology, University of British Columbia. Age: 34

1 Comment

image: Erica Larschan: Hitting Her Targets

Erica Larschan: Hitting Her Targets

By | November 1, 2012

Assistant Professor, Molecular Biology, Cell Biology, & Biochemistry Brown University, Age: 36

1 Comment

image: David Sabatini: Demystifying mTOR

David Sabatini: Demystifying mTOR

By | March 1, 2012

Principal Investigator, Whitehead Institute for Biomedical Research. Associate Professor, Department of Biology, Massachusetts Institute of Technology. Age: 44

0 Comments

image: Lynne-Marie Postovit: Cancer Modeler

Lynne-Marie Postovit: Cancer Modeler

By | January 1, 2012

Assistant Professor, Department of Anatomy and Cell Biology, University of Western Ontario. Age: 34

3 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS